Specific Biologics
Specific Biologics is a biotech company in Toronto, Canada, founded in 2017. It has raised $35.0M across 1 round, most recently a $35.0M Series A in November 2026.
- Headquarters
- Toronto, Ontario
- Employees
- 1–10
- Founded
- 2017
- Website
- specificbiologics.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Series ANov 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Specific Biologics develops Dualase genome editors as potential medicines for genetic diseases. Its two-site editing mechanism enables removal, repair, and insertion of small or large sequences. Its therapeutic pipeline targets central nervous system, lung, and liver indications, with an initial focus on precisely removing expanded DNA repeats and correcting underlying genetic drivers of disease.
Summary
It lists 1–10 employees. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Nov 2026.
Funding History
Nov 2026
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/specific-biologics"><img src="https://indexed.vc/api/badge/company/specific-biologics" alt="Specific Biologics on Indexed.vc" width="260" height="76" /></a>